The effect of FCGR3A genotypes on EULAR response, low disease activity and complete remission
| VV | VF | FF | V (VV+VF) | F (FF+VF) | Dominant model (VV+VF) vs FF OR (95% CI) | Recessive model VV vs (VF+FF) OR (95% CI) | |
| Patient number (%) | 8 (15.4) | 34 (65.4) | 10 (19.2) | 42 (80.8) | 44 (84.6) | ||
| EULAR response (%) | 5 (62.5) | 25 (73.5) | 6 (60.0) | 30 (71.4) | 31 (70.4) | 1.667 (0.398 to 6.976) p=0.475 | 0.699 (0.145 to 3.364) p=0.689 |
| Low disease activity (%) | 5 (62.5) | 22 (64.7) | 3 (30.0) | 27 (64.2) | 25 (56.8) | 4.200 (0.944 to 18.690) p=0.075 | 1.267 (0.269 to 5.974) p=1.000 |
| Complete remission (%) | 3 (37.5) | 11 (32.4) | 3 (30.0) | 14 (33.3) | 14 (33.3) | 1.167 (0.261 to 5.212) p=1.000 | 1.286 (0.269 to 6.155) p=1.000 |
EULAR, European League Against Rheumatism.